Blaine Pharmaceuticals Private Limited
About Blaine Pharmaceuticals Private Limited
Data last updated:
Blaine Pharmaceuticals Private Limited is a private limited company based in Haridwar, Uttarakhand, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 19 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U51909UR2019PTC009930. Its GSTIN is 05AAICB5032A1ZD (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Deepak and Somveer Singh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 18 &19A Rohini Enclave Near Mantra City Sidcul, Haridwar, Uttarakhand, India – 249403.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.73 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹3.5 Lakh (net margin 1.3%) and EBITDA of ₹17.54 Lakh (EBITDA margin 6.4%). Revenue has grown at a compounded annual rate (CAGR) of 55% over three years.
The company has about 14 employees on its provident fund (EPFO) records.
Company details
Contact details
Blaine Pharmaceuticals Private Limited's registered office is in Haridwar, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No 18 &19A Rohini Enclave Near Mantra City Sidcul, Haridwar, Uttarakhand, India – 249403
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Blaine Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Blaine Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Blaine Pharmaceuticals Private Limited, buy the company report.
Financials of Blaine Pharmaceuticals Private Limited
FY 2025 filings availableBlaine Pharmaceuticals Private Limited reported revenue of ₹2.73 Cr (up 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 55% over three years, including 25% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.4% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Blaine Pharmaceuticals Private Limited, buy the company report.
Board of directors of Blaine Pharmaceuticals Private Limited
Blaine Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak | Director | 14 Nov 2019 | 6 Years 11 Months | Current |
| Somveer Singh | Director | 14 Nov 2019 | 6 Years 11 Months | Current |
| Mayank Kumar | Director | 19 Jun 2019 | 7 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Blaine Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Blaine Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Blaine Pharmaceuticals Private Limited has a workforce of 14 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 14 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Blaine Pharmaceuticals Private Limited, buy the company report.
GST
Blaine Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAICB5032A1ZD | Uttarakhand | Active | 18 Jul 2019 |
To see the full GST registrations and return filing status of Blaine Pharmaceuticals Private Limited, buy the company report.
Recent activity
Blaine Pharmaceuticals Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Ashok Kumar ceased to be Director on 21 Feb 2025.
Frequently asked questions
Blaine Pharmaceuticals is an active private limited company based in Haridwar, Uttarakhand, India. The company works in specialty, within the trading industry. It was incorporated on 19 June 2019 (7+ years old) and is registered under CIN U51909UR2019PTC009930.
Blaine Pharmaceuticals has 3 current directors:
- Deepak - Director
- Somveer Singh - Director
- Mayank Kumar - Director
The latest financial statements of Blaine Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Blaine Pharmaceuticals is 05AAICB5032A1ZD, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Blaine Pharmaceuticals is U51909UR2019PTC009930. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Blaine Pharmaceuticals was incorporated on 19 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttarakhand.
Ashok Kumar ceased to be Director on 21 Feb 2025. Deepak was appointed as Director on 14 Nov 2019. Somveer Singh was appointed as Director on 14 Nov 2019. Blaine Pharmaceuticals has 4 board changes on record in total.
The registered office of Blaine Pharmaceuticals is at Plot No 18 &19A Rohini Enclave Near Mantra City Sidcul, Haridwar, Uttarakhand, India – 249403.
Blaine Pharmaceuticals operates in the trading industry, in the specialty segment.
Blaine Pharmaceuticals can be reached at its registered office: Plot No 18 &19A Rohini Enclave Near Mantra City Sidcul, Haridwar, Uttarakhand, India – 249403.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
